Hint mode is switched on Switch off
For swift navigation between sections

Herantis Pharma
LEI 743700W4CQVYAT3WKK38

Organization name
Herantis Pharma PLC
Country name
Finland
Country of registration
Finland
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Herantis Pharma PLC is a pharmaceutical drug development company. It focused on developing regenerative medicine for unmet clinical needs. The products of the group are CDNF for Parkinson's disease, Lymfactin for secondary lymphedema, CDNF for Amyotrophic lateral sclerosis and CDNF for other neurodegenerative diseases. The corporation is based in Finland.

Awards

Documentation

Stocks

Public debt by currencies

Codes

  • LEI
    743700W4CQVYAT3WKK38
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • Business ID
    2198665-7
Registration is required to get access.